Navigation Links
Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome
Date:5/19/2008

San Diego, California, May 19, 2008 NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported the presentation of Phase 3 data at the annual Digestive Disease Week (DDW) Congress on GATTEX (teduglutide), a novel investigational compound that may reduce dependence upon parenteral nutrition (PN) in patients with intestinal failure associated with short bowel syndrome (SBS).

The Phase 3 study evaluated two doses of GATTEX versus placebo. Results indicate that GATTEX was generally well-tolerated and effective in reducing the PN requirements of SBS patients, with the lower dose findings showing statistical significance versus placebo. The company is finalizing a protocol for a Phase 3 confirmatory study, which it expects will begin in the third quarter of 2008. Stephen OKeefe, M.D., professor of medicine, University of Pittsburgh, presented the Phase 3 results today at an American Gastroenterological Association (AGA) Institute clinical science plenary session.

Data from this study show that GATTEX has the potential to reduce or eliminate the need for parenteral nutrition, thereby reducing the complications associated with PN therapy and improving quality of life for patients with intestinal failure due to surgical resection (SBS), said Dr. OKeefe. These latest findings provide further support for the development of GATTEX as a potential first-in-class compound to reduce the dependency of SBS patients on IV fluids and nutrition without adverse side effects.

The pivotal Phase 3 study evaluated 83 SBS patients who are dependent on PN. After a PN stabilization and optimization period, patients were randomized to receive low-dose of GATTEX (0.05 mg/kg/day), high-dose GATTEX (0.10 mg/kg/day) or placebo for 24 weeks. A clinically significant PN response was defined as a weekly reduction of PN requirements of more than 20% at dosing week 20 and maintained through dosing week 24.

Key findings were as follows:


  • '/>"/>

Contact: Stephen Bingham
609-514-5117
JFK Communcations
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New AMITIZA 8 mcg phase III studies demonstrated overall symptom improvement in adult women
2. AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
3. Phase III pivotal results presented of VYVANSE to treat ADHD in adults
4. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
5. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
6. Phase 3 data Re: Anti-RSV antibody to be presented at Pediatric Academic Societies Annual Meeting
7. Wal-Mart Launches Phase Three of $4 Prescription Program
8. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
9. Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
10. Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data
11. QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... “ Wants and Needs ” was featured on NewsWatch ... latest and coolest mobile applications on the iOS, Android, ... and host of NewsWatch, conducted the app review and ... priorities. , Whether a person needs help re-orienting or ... app allows people to enter and track wants, both ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... LegitScript, LLC, operator of ... including those for Internet pharmacy certification, monitoring ... classification, has launched a certification program for ... program, called iCareRx , provides certification ... identity of the owner/operator of Internet websites, ...
(Date:3/2/2015)... 2015 A true renaissance man—some might call ... 1960s cult rock band Khazad Doom, has long inspired his ... persevere despite all odds. His motto throughout his life has ... or goal was before him. And that attitude, born amidst ... passed on to a new generation. , As Eadon knows, ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3
... a mirror of the inner self. However, according to a new ... stroke-related death. // ,The study, published in the October ... the eyes to determine whether people have a higher risk of ... tiny lesions on the back of the eye are two to ...
... A new study published in the October 17 issue of ... fight inflammation in the gut. This feature may help the ... a foreign particle//. ,Fat rich foods stimulate the ... hormone called cholecystokinin, or CCK. This enzyme is responsible for ...
... elbow has been enjoying the spot light following ace cricketer ... However, the condition is not uncommon in the sports arena//. ... called in medical parlance, is an affliction where the outer ... a result of a specific strain, overuse or a direct ...
... for cardiovascular disease in both men and women, which ... subjects and that 80 percent of all type 2 ... In these patients hyperglycemia per se confers ... of even borderline-high-risk LDL-C signals the need for more ...
... out the benefits of oral ZYVOX for the treatment ... They compared data from 80 health care clinics and ... Vancomycin. The results show that oral tablets of Linezolid ... spent to health clinics compared to vancomycin. ...
... Terminally ill people have the right to a life of ... the pain which often accompanies diseases like cancer, say experts ... // . ,Currently, only a few states like Kerala, ... have provisions that allow care-giving organisations to administer strong pain ...
Cached Medicine News:Health News:Lesions in the eyes may forecast a stroke 2Health News:Tennis elbow not new among cricketers, say experts 2Health News:Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections 2Health News:Terminally Ill deserves a better quality of Life 2Health News:Terminally Ill deserves a better quality of Life 3
(Date:3/2/2015)... Calif. , March 2, 2015  CytomX, ... treatment of cancer, today announced the creation of ... researchers and clinicians in the fields of cancer ... The new advisory boards will provide guidance to ... pipeline of precision immunotherapies and Probody drug conjugates. ...
(Date:3/2/2015)... March 2, 2015 Leading patient advocacy organization ... the 2015 One Million Strong ... will raise awareness and funds for colorectal cancer education, ... million colorectal cancer survivors living in the ... great strength and courage every day. Showing ...
(Date:3/2/2015)... 2, 2015  The International Myeloma Foundation (IMF), ... myeloma patients while working toward prevention and a ... March to be Myeloma Awareness Month (#MAM). ... Awareness Month in 2009. Throughout the month, the ... community events, social media campaigns, story sharing, and ...
Breaking Medicine Technology:CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5International Myeloma Foundation Declares March "Myeloma Awareness Month" 2International Myeloma Foundation Declares March "Myeloma Awareness Month" 3
... BETHLEHEM, Pa., July 12, 2011 ... and Absorption Systems, a leading provider of pre-clinical ... are working together to provide their clients with ... data into the dosage form development scheme.   ...
... UBM TechInsights, the leader in technical intelligence and ... that medical devices industry veteran Bill Betten has joined ... this role Mr. Betten will draw upon his years ... sector maximize the effectiveness of the product innovation processes ...
Cached Medicine Technology:Particle Sciences and Absorption Systems Form Relationship to Offer their Clients Enhanced Services 2UBM TechInsights Hires Medical Devices Industry Veteran Bill Betten 2
A portable, easy to use, dual-channel laser-Doppler tissue perfusion and temperature monitoring system, at a remarkably affordable price....
... high performance laser doppler system for ... blood perfusion. This latest generation single-channel ... with its multi-channel brother (Oxyflo), including ... and laser doppler flowmetry providing a ...
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
Medicine Products: